Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Journal of Neuropathology and Experimental Neurology|July 31, 2018
Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral EdemaMatthew Torre, Isaac H Solomon, Claire L Sutherland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2014
Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survivalJohn Koreth, Haesook T Kim, Sarah Nikiforow, et al.
Transplantation and Cellular Therapy|May 4, 2024
Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center AnalysisHaesook T Kim, Vincent T Ho, Sarah Nikiforow, et al.
Blood Advances|April 19, 2022
Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosisMahasweta Gooptu, Haesook T Kim, Eric Jacobsen, et al.
The New England Journal of Medicine|March 13, 2024
Intraventricular CARv3-TEAM-E T Cells in Recurrent GlioblastomaBryan D Choi, Elizabeth R Gerstner, Matthew J Frigault, et al.
Transfusion|July 11, 2026
Comparative analysis of motixafortide versus plerixafor for stem cell mobilization and collection in multiple myeloma: A single center real-world experienceSara Close, Jun Liu, Lara Abousamra, et al.
Haematologica|April 10, 2025
Reduced incidence of relapse and graft-<i>versus</i>-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantationHaesook T Kim, Robert J Soiffer, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 7, 2018
Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell TransplantationLindsey E Roeker, Haesook T Kim, Brett Glotzbecker, et al.
Haematologica|January 16, 2016
Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantationPaul S Martin, Shuli Li, Sarah Nikiforow, et al.
Blood Advances|July 19, 2023
A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can helpKevin J Curran, Sarah Nikiforow, Carlos Bachier, et al.
Pageof 13